| Literature DB >> 34063711 |
Francesco Petrillo1, Danilo Pignataro2, Federica Maria Di Lella2, Michele Reibaldi3, Matteo Fallico1, Niccolò Castellino1, Guglielmo Parisi3, Maria Consiglia Trotta4, Michele D'Amico4, Biagio Santella2, Veronica Folliero2, Maria Teresa Della Rocca2, Michele Rinaldi5, Gianluigi Franci6, Teresio Avitabile1, Marilena Galdiero2, Giovanni Boccia6.
Abstract
Ocular bacterial infections represent a serious problem that affecting people of all age and genders. These infections can lead to visual impairment and blindness if not properly treated. The current study evaluates the antimicrobial resistance profiles and the resistance trend of both Staphylococcus aureus (S. aureus) and coagulase-negative staphylococci (CoNS), the main pathogens involved in eye infections. A total of 322 isolates of S. aureus and CoNS, were collected from patients with bacterial conjunctivitis and keratitis at the "Luigi Vanvitelli" University Hospital of Campania in Naples, Italy, between 2017 and 2020. The isolated bacteria showed a high percentage of resistance to methicillin and other antibiotics commonly used for the treatment of ocular infections. Trends in antibiotic resistance were not encouraging, recording-especially among CoNS strains-an increase of more than 20% in resistance to methicillin and aminoglycosides during the study period. Instead, the resistance rates to tetracycline had a significant decrease in CoNS isolates while no changes in their susceptibility to fluoroquinolones and macrolides were observed. However, all isolates showed no resistance to trimethoprim/sulfamethoxazole and chloramphenicol. In this scenario, preventive identification of the infection causative agents and the evaluation of the antimicrobial susceptibility patterns are essential to set up an ocular infection effective drug treatment and also prevent antibiotic resistance.Entities:
Keywords: bacterial; drug resistance; eye infections; hospitals; methicillin-resistant staphylococcus aureus
Year: 2021 PMID: 34063711 PMCID: PMC8147806 DOI: 10.3390/antibiotics10050527
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Gender and age distribution of study population.
| Gender | n (%) | |
|---|---|---|
| Male | 155 (48.1%) | - |
| Female | 167 (51.9%) | - |
|
|
|
|
| 0–30 years old | 26 (8.0%) | - |
| 31–60 years old | 81 (25.2%) | - |
| 61–90 years old | 215 (66.8%) | <0.05 * |
* Chi-square test was conducted between the resistance rates for the MR-Cons and MR-S. aureus bacterial strains. p-value ≤ 0.05 was statistically significant.
Resistance percentages of different antibiotics between 2017 and 2020 among CoNS and S. aureus isolates.
| Antimicrobial Agent | % CoNS | % | |
|---|---|---|---|
| Ampicillin | 61.7 | 23.7 | <0.05 * |
| Amoxicillin-Clavulanic Acid | 61.7 | 23.7 | <0.05 * |
| Cefoxitin | 61.7 | 23.7 | <0.05 * |
| Gentamycin | 72.8 | 41.7 | 0.05 * |
| Tobramycin | 72.8 | 41.7 | 0.05 * |
| Clindamycin | 87.5 | 56.0 | <0.05 * |
| Erythromycin | 81.9 | 45.8 | 0.001 * |
| Tetracycline | 58.5 | 28.6 | <0.05 * |
| Ciprofloxacin | 84.2 | 47.6 | <0.05 * |
| Moxifloxacin | 84.2 | 47.6 | <0.05 * |
| Neomycin | 72.8 | 41.7 | 0.05 * |
| Chloramphenicol | 0 | 0 | - |
| Trimethoprim Sulfamethoxazole | 0 | 0 | - |
* Chi-square was conducted between the resistance rates for the MR-Cons and MR-S. aureus bacterial strains. p-value ≤ 0.05 was statistically significant.
Figure 1Susceptibility rates of CoNS strains for different tested antibiotics classes in 2017–2020.
Figure 2Susceptibility rates of S. aureus isolated strains for different tested antibiotics classes in 2017–2020.